• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, May 14, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Nerve growth factor: Early studies and recent clinical trials

Bioengineer by Bioengineer
January 18, 2019
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Luigi Aloe et al. is published in Current Neuropharmacology, Volume 16 , Issue 10 , 2018

Nerve growth factor has been playing an important role in development of adult neurobiology. This is because of the regulatory functions that it possesses on survival, growth and differentiation of nerve cells in both of the central and peripheral nervous systems. Nerve growth factor plays an action in survival and growth of peripheral, sympathetic and sensory neurons along on numerous amounts of brain neurons. As far as neuropathic factors are concerned, NGF is the first discovered member of a family collectively indicated as neurotrophins. This includes, brain derived neurophin 4/5, neurotrophin-3 and nuerotrophic factor. For the sake of survival and differentiation of much selected population of peripheral neurons, NGF was discovered. Therefore, many studies took place to identify the role of purified NGF just for the sake of prevention of deaths of NGF-receptive cells. After all the studies, it was revealed to the researchers that NGF possesses good amount of therapeutic properties for diseases like, cutaneous ulcer, corneal ulcers, glaucoma, retinal maculopathy, Retinitis Pigmentosa along with optic gliomas and brain traumas.

Therefore, the researches and studies that took place on NGF showed new routes for the diagnostics along with that allowed safe amount of dosages to the effected patients. This thing widened the spectrum of therapy with the help of NGF based therapy.

###

Media Contact
Faizan ul Haq
[email protected]
http://dx.doi.org/10.2174/1570159X16666180412092859

Tags: Clinical TrialsInternal MedicineMedicine/HealthneurobiologyPharmaceutical Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Maveropepimut-S Combo Shows Promise in Ovarian Cancer

May 14, 2026

New Global Study Reveals Challenges in Combating High Blood Pressure Effectively

May 13, 2026

Randomised Controlled Trial Finds Semaglutide Effective for Severe Obesity in Long-Term Treatment-Resistant Young Patients

May 13, 2026

Unraveling Dementia Networks in Singapore’s Elderly

May 13, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    842 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    729 shares
    Share 291 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Triple-Negative Breast Cancer Ecotypes and Chemotherapy Response

Maveropepimut-S Combo Shows Promise in Ovarian Cancer

Gaussian Boson Sampling: 1,024 Squeezed States, 8,176 Modes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.